New quinazolinone-thiazolidinedione hybrids as selective anti-lung cancer agents and promising EGFR inhibitors
These findings indicate that the synthesized hybrids, particularly compound <b>9</b>, represent promising leads for selective EGFR-targeted lung cancer therapy and support further optimization.
Authors
- Fahri AKBAŞ
- Pelin Tokalı
- Şeyma Ateşoğlu (ORCID: https://orcid.org/0000-0001-7540-1456)
- Feyzi Sinan Tokali
- Furkan Çakır
- Ayşe Merve Şenol
- Halil Şenol
Institutions
- Kafkas University (TR)
- University of Health Science (KH)
- Bezmiâlem Vakıf Üniversitesi (TR)
Publication Details
- Journal
- Future Medicinal Chemistry
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1080/17568919.2026.2620368
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00